ArticlePLoS pathogens2026
De novo nucleotide biosynthesis and its dynamic regulation are crucial for systemic infection by extraintestinal Escherichia coli.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extraintestinal Escherichia coli (ExPEC) proliferates rapidly in the bloodstream, causing life-threatening systemic infections with high mortality rates. Understanding how ExPEC adapts to the blood environment is essential for elucidating its pathogenesis and identifying potential antimicrobial targets. Using transposon mutagenesis-based high-throughput screening, we systematically identified genes critical for ExPEC growth in serum. Our findings demonstrate that de novo nucleotide biosynthesis genes are indispensable for serum proliferation, and animal infection assays further confirm their vital role in ExPEC virulence. Genetic disruption of this pathway did not affect bacterial stress response or adhesion capacity but severely impaired ExPEC's intracellular survival in macrophages. Transcriptomic profiling combined with a luminescent reporter system revealed significant upregulation of de novo nucleotide biosynthesis genes during both serum incubation and systemic infection. This upregulation was mediated by the transcriptional repressor PurR, and could be inhibited by purine supplementation. Furthermore, enhanced in vivo fitness was observed for the purR deletion strain, whereas the opposite was seen for the purR overexpression strain, indicating a crucial role for PurR in ExPEC pathogenesis. Quantitative analyses showed that serum incubation significantly depletes intracellular purine pools in ExPEC. Electrophoretic mobility shift assays (EMSA) demonstrated that specific purines modulate PurR-DNA binding affinity. These results suggest that PurR acts as a sensor of intracellular purine concentration changes, regulating de novo nucleotide biosynthesis genes to facilitate host environment adaptation. This study reveals the essential role of de novo nucleotide biosynthesis in ExPEC virulence and describes a pathogenesis mechanism involving nucleotide metabolism regulation to overcome nutritional immunity, offering a foundation for developing therapies against systemic ExPEC infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.